Cell And Gene Articles, App Notes, Case Studies, & White Papers

  1. Enhanced Development Of Virus-Specific Hybridomas 3/10/2025

    Double-stranded DNA viruses cause various human diseases, which complicates diagnosis due to antigen conservation. Explore a cell line that produces specific monoclonal antibodies to aid biotherapeutics development.

  2. A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications 6/9/2025

    Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

  3. Lentiviral Vector Characterization For Cell And Gene Therapy Manufacturing 6/20/2024

    This study focuses on characterizing recombinant LVVs used in gene-modified cell therapies, utilizing two real-time PCR assays adapted to the QuantStudio™ Absolute Q™ Digital PCR System.

  4. Bladder Cancer Global Clinical Trial Landscape (2024) 11/12/2024

    Bladder cancer is the ninth most common cancer in the world and thirteenth in mortality. This report provides a detailed overview of the clinical trial landscape for bladder cancer.

  5. The Case For A New Paradigm In Geographic Atrophy Clinical Trials 10/15/2025

    Here, the author introduces a new framework for GA clinical development that integrates genetic profiling, novel biomarkers, and predictive analytics to improve precision, streamline design, and accelerate development.

  6. Exploring Perfusion Technology For Virus Manufacturing Process Intensification 1/28/2025

    Perfusion cell culture technology supports high cell densities and product yields for viral vaccine manufacturing, offering a reliable way to produce high-quality cells at a commercial scale.

  7. Ready To Demystify Organoids? 7/1/2025

    Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.

  8. Prefabricated Viral Vector Modular BSL-2LS cGMP Facility In 13 Months 6/26/2024

    Learn about the modular BSL-2LS cGMP facility that was constructed to support 3 processing lines for German-based CDMO Vibalogics as the company sought to expand in the U.S. market for viral vectors.

  9. Relieving The Strain Of Publishing During Regulatory Registration 8/7/2024

    Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.

  10. A Paradigm Shift From Glass Benchtop Bioreactors 8/14/2025

    Learn how a bench-scale single-use bioreactor offers process development advantages over traditional glass systems, including higher efficiency, increased productivity, and enhanced sustainability.